Login  /  Register  | 3 premium articles left before you must register.

Pfizer joins cancer consortium

Published 12/14/2012 12:00 AM
Updated 12/13/2012 11:03 PM

Pfizer Inc. has joined a worldwide consortium to promote expanded opportunities for personalized cancer medicines.

The pharmaceutical giant, with R&D labs in Groton, became the first drug company to sign onto the Worldwide Innovative Network, based in France.

"Pfizer will play an integral role in shaping the future achievements of this collective group on behalf of cancer patients around the world," WIN said in a statement. "Pfizer's advanced capabilities in the development of targeted oncology therapies will provide a breadth of insights and opportunities to the consortium."

Pfizer's oncology research unit is based in LaJolla, Calif.

For information, go to www.winconsortium.org.

Town News

Visit Zip06
Submit Your:  Submit Your News Submit Your Photos Submit Your Events
Most Recent Poll
The seven Big East Catholic schools appear poised to leave the conference. What do you think of the course the Big East has taken in recent years?
It's disgusting. A proud basketball tradition was squandered for mediocre football and television contracts.
44%
It's not ideal but it had to happen. The money is in football and teams like UConn and Syracuse needed to adapt.
14%
I think we waste our time and energy focusing on sports. Aren't there bigger problems in the world?
43%
Number of votes: 80

No current items found